Review of drug treatment of oral submucous fibrosis

Oral Oncology

Volumn 48, Issue 5, 2012, Pages 393-398

  Chole, Revant H ^a   Gondivkar, Shailesh M ^b   Gadbail, Amol R ^c   Balsaraf, Swati ^d   Chaudhary, Sudesh ^e   Dhore, Snehal V ^e   Ghonmode, Sumeet ^f   Balwani, Satish ^g   Mankar, Mugdha ^c   Tiwari, Manish ^d   Parikh, Rima V ^h  

^a Modern Dental College and Research Center   (India)

^b MGV's KBH Dental College and Hospital   (India)

^c DATTA MEGHE INSTITUTE OF MEDICAL SCIENCES   (India)

^d Research Centre   (India)

^e SDKS Dental College and Hospital   (India)

^f GOVERNMENT DENTAL COLLEGE AND HOSPITAL   (India)

^g SMBT Dental College and Hospital   (India)

^h NONE

Author keywords

Oral submucous fibrosis; Treatment

Indexed keywords

BETAMETHASONE; BUFLOMEDIL; BUPHENINE; CHYMOTRYPSIN; COLLAGENASE; CORTICOSTEROID; CURCUMA LONGA EXTRACT; DEXAMETHASONE; FERROUS FUMARATE; GAMMA INTERFERON; HYALURONIDASE; HYDROCORTISONE; IODINE; IRON; LYCOPENE; MULTIVITAMIN; PENTOXIFYLLINE; PLACEBO; PLACENTA EXTRACT; RETINOL; STEROID; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE; TURMERIC; VITAMIN B COMPLEX;

AYURVEDA; BURNING SENSATION; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DRUG ERUPTION; FEVER; GASTRITIS; HOT FLUSH; HUMAN; HYPERTHERMIC THERAPY; MILK; MOUTH DISEASE; MOUTH ULCER; OUTCOME ASSESSMENT; PHYSIOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; STEROID THERAPY; STOMACH IRRITATION; TRISMUS;

ADRENAL CORTEX HORMONES; ANTIOXIDANTS; CLINICAL TRIALS AS TOPIC; COMPLEMENTARY THERAPIES; FEMALE; HUMANS; HYDROLASES; MALE; ORAL SUBMUCOUS FIBROSIS; TRACE ELEMENTS; TREATMENT OUTCOME; VASODILATOR AGENTS; VITAMINS;

EID: 84859958071     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2011.11.021     Document Type: Review

References (35)

1. Warnakulasuriya S, Johnson NW, Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 2007;36:575-80. (Pubitemid 47609807)
2. Aziz SR. Oral submucous fibrosis: an unusual disease. J N J Dent Assoc 1997;68:17-9.
3. Paissat DK. Oral submucous fibrosis. Int J Oral Surg 1981;10:307-12. (Pubitemid 12080089)
4. Schwartz J. Atrophia idiopathica (tropica) mucosae oris. London: Proceedings of the 11th International Dental Congress, 1952.
5. Joshi SG. Fibrosis of the palate and pillars. Indian J Otolaryngol 1953;4:1.
6. Mathew AL, Pai KM, Sholapurkar AA, Vengal M. The prevalence of oral mucosal lesions in patients visiting a dental school in Southern India. Indian J Dent Res 2008;19:99-103.
7. Murti PR, Bhonsle RB, Pindborg JJ, Daftary DK, Gupta PC. Mehta FS: Malignant transformation rate in oral submucous fibrosis over a 17-year period. Community Dent Oral Epidemiol 1985;13:340-1.
8. Pindborg JJ, Murti PR, Bhonsle RB, Gupta PC, Daftary DK. Mehta FS: oral submucous fibrosis as a precancerous condition. Scand J Dent Res 1984;92:224-9.
9. Pindborg JJ. Oral submucous fibrosis: a review. Ann Acad Med Singapore 1989;18:603-7. (Pubitemid 19265685)
10. Shiau YY, Kwan HW. Submucous fibrosis in Taiwan. Oral Surg Oral Med Oral Pathol 1979;47:453-7. (Pubitemid 10205237)
11. Canniff JP, Harvey W, Harris M. Oral submucous fibrosis: its pathogenesis and management. Br Dent J 1986;160:429-34.
12. Rajendran R, Vasudevan DM, Vijayakumar T. Serum iron and proteins in oral submucous fibrosis (OSMF). Ann Dent 1990;49:23-5. 45.
13. Gupta DS, Gupta M, Oswal RH. Estimation of major immunoglobulin profile in oral submucous fibrosis by radial immunodiffusion. Int J Oral Surg 1985;14:533-7. (Pubitemid 16176377)
14. Chang YC, Hu CC, Tseng TH, Tai KW, Lii CK, Chou MY. Synergetic effects of nicotine on arecoline-induced cytotoxicity in human buccal mucosal fibroblasts. J Oral Pathol Med 2001;30:458-64.
15. Manoharan S, Kolanjiappan K, Suresh K, Panjamurthy K. Lipid peroxidation and antioxidants status in patients with oral squamous cell carcinoma. Indian J Med Res 2005;122:529-34.
16. Pillai R, Balaram P, Reddiar KS. Pathogenesis of oral submucous fibrosis. Relationship to risk factors associated with oral cancer. Cancer 1992;69:2011-20.
17. Chiang CP, Hsieh RP, Chen TH, Chang YF, Liu BY, Wang JT, et al. High incidence of autoantibodies in Taiwanese patients with oral submucous fibrosis. J Oral Pathol Med 2002;31:402-9. (Pubitemid 34973687)
18. Jiang X, Hu J. Drug treatment of oral submucous fibrosis: a review of the literature. J Oral Maxillofac Surg 2009;67:1510-5.
19. Fedorowicz Z, Chan Shih-Yen E, Dorri M, Nasser M, Newton T, Shi L. Interventions for the management of oral submucous fibrosis. Cochrane Database Syst Rev 2008: CD007156.
20. Aziz SR. Lack of reliable evidence for oral submucous fibrosis treatments. Evid Based Dent 2009;10:8-9.
21. Gupta D, Sharma SC. Oral submucous fibrosis - A new treatment regimen. J Oral Maxillofac Surg 1988;46:830-3.
22. Borle RM, Borle SR. Management of oral submucous fibrosis: a conservative approach. J Oral Maxillofac Surg 1991;49:788-91.
23. Lai DR, Chen HR, Lin LM, Huang YL, Tsai CC. Clinical evaluation of different treatment methods for oral submucous fibrosis. A 10-year experience with 150 cases. J Oral Pathol Med 1995;24:402-6.
24. Kakar PK, Puri RK, Venkatachalam VP. Oral submucous fibrosis-treatment with hyalase. J Laryngol Otol 1985;99:57-9.
25. Maher R, Aga P, Johnson NW, Sankaranarayanan R, Warnakulasuriya S. Evaluation of multiple micronutrient supplementation in the management of oral submucous fibrosis in Karachi, Pakistan. Nutr Cancer 1997;27:41-7. (Pubitemid 26424314)
26. Sharma JK, Gupta AK, Mukhija RD, Nigam P. Clinical experience with the use of peripheral vasodilator in oral disorders. Int J Oral Maxillofac Surg 1987;16:695-9. (Pubitemid 18025816)
27. Li X, Tang J. Clinical treatment observation of tea pigment for oral submucous fibrosis. Hua Xi Kou Qiang Yi Xue Za Zhi 1998;16:50-2.
28. Kumar A, Bagewadi A, Keluskar V, Singh M. Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103:207-13.
29. Samlaska CP, Winfield EA. Pentoxifylline. J Am Acad Dermatol 1994;30:603-21. (Pubitemid 24121761)
30. Rajendran R, Rani V, Shaikh S. Pentoxifylline therapy: a new adjunct in the treatment of oral submucous fibrosis. Indian J Dent Res 2006;17:190-8.
31. Tai YS, Liu BY, Wang JT, Sun A, Kwan HW, Chiang CP. Oral administration of milk from cows immunized with human intestinal bacteria leads to significant improvements of symptoms and signs in patients with oral submucous fibrosis. J Oral Pathol Med 2001;30:618-25. (Pubitemid 32974482)
32. Haque MF, Meghji S, Nazir R, Harris M. Interferon gamma (IFN-gamma) may reverse oral submucous fibrosis. J Oral Pathol Med 2001;30:12-21.
33. Joshi J, Ghaisas S, Vaidya A, Vaidya R, Kamat DV, Bhagwat AN, et al. Early human safety study of turmeric oil (Curcuma longa oil) administered orally in healthy volunteers. J Assoc Physicians India 2003;51:1055-60. (Pubitemid 41279813)
34. Hastak K, Lubri N, Jakhi SD, More C, John A, Ghaisas SD, et al. Effect of turmeric oil and turmeric oleoresin on cytogenetic damage in patients suffering from oral submucous fibrosis. Cancer Lett 1997;116:265-9. (Pubitemid 27283017)
35. Kerr AR, Warnakulasuriya S, Mighell AJ, Dietrich T, Nasser M, Rimal J, et al. A systematic review of medical interventions for oral submucous fibrosis and future research opportunities. Oral Dis 2011;17:42-57.